We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+15.33%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$112M
AUM Growth
-$4.51M
(-3.9%)
Cap. Flow
-$14.3M
Cap. Flow
% of AUM
-12.78%
Top 10 Holdings %
Top 10 Hldgs %
35.03%
Holding
122
New
10
Increased
13
Reduced
73
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
QUMU
Qumu Corp.
QUMU
|
+$1.17M |
| 2 |
ASPU
ASPEN GROUP, INC.
ASPU
|
+$1.01M |
| 3 |
BIOL
Biolase, Inc.
BIOL
|
+$812K |
| 4 |
AKTS
Akoustis Technologies Inc
AKTS
|
+$759K |
| 5 |
FPAY
FlexShopper
FPAY
|
+$397K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTLP
Cantaloupe
CTLP
|
+$1.71M |
| 2 |
TEUM
Pareteum Corporation
TEUM
|
+$1.52M |
| 3 |
Apyx Medical
APYX
|
+$1.13M |
| 4 |
Natera
NTRA
|
+$995K |
| 5 |
Vericel Corp
VCEL
|
+$774K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.18% |
| 2 | Technology | 12.18% |
| 3 | Industrials | 6.62% |
| 4 | Communication Services | 6.04% |
| 5 | Consumer Staples | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRAY
76
DELISTED
ViewRay, Inc.
VRAY
| $331K | 0.3% |
78,500
+19,400
| +33% | +$62.7K |
|
77
NXP Semiconductors
NXPI
$57.8B
| $325K | 0.29% |
2,550
| – | – |
|
78
Champions Oncology
CSBR
$74.5M
| $317K | 0.28% |
38,000
-27,500
| -42% | -$170K |
|
79
Medtronic
MDT
$109B
| $306K | 0.27% |
2,700
-1,500
| -36% | -$165K |
|
80
Best Buy
BBY
$18.2B
| $299K | 0.27% |
3,400
-1,500
| -31% | -$115K |
|
|
IIN
81
DELISTED
IntriCon Corporation
IIN
| $294K | 0.26% |
+16,325
| New | +$313K |
|
82
Sportsman's Warehouse
SPWH
$44.5M
| $285K | 0.26% |
35,500
-35,500
| -50% | -$251K |
|
83
Inogen
INGN
$175M
| $258K | 0.23% |
+3,775
| New | +$237K |
|
|
NVIV
84
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| $253K | 0.23% |
+1,500
| New | +$373K |
|
85
Asure Software
ASUR
$232M
| $245K | 0.22% |
30,000
-12,500
| -29% | -$104K |
|
86
GE Aerospace
GE
$374B
| $243K | 0.22% |
4,366
-602
| -12% | -$31.1K |
|
87
IZEA Worldwide
IZEA
$60.6M
| $229K | 0.21% |
242,375
-5,700
| -2% | -$6K |
|
88
Option Care Health
OPCH
$3.45B
| $226K | 0.2% |
15,125
-5,125
| -25% | -$69.3K |
|
89
Dyadic International
DYAI
$38.3M
| $220K | 0.2% |
42,500
| – | – |
|
90
Radiant Logistics
RLGT
$386M
| $214K | 0.19% |
38,500
-20,000
| -34% | -$108K |
|
|
TYME
91
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $197K | 0.18% |
141,000
-1,500
| -1% | -$1.82K |
|
|
MNDT
92
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $195K | 0.17% |
11,811
-250
| -2% | -$4.01K |
|
93
KORU Medical Systems
KRMD
$189M
| $176K | 0.16% |
+27,000
| New | +$132K |
|
|
ZIXI
94
DELISTED
Zix Corporation
ZIXI
| $170K | 0.15% |
25,000
| – | – |
|
95
Airgain
AIRG
$73.4M
| $166K | 0.15% |
15,500
-50,300
| -76% | -$528K |
|
96
TELA Bio
TELA
$32.7M
| $130K | 0.12% |
+10,000
| New | +$122K |
|
97
IRIDEX
IRIX
$14.3M
| $120K | 0.11% |
53,600
+9,250
| +21% | +$19.5K |
|
|
FOCL
98
EDAP TMS S.A.
FOCL
$229M
| $111K | 0.1% |
25,000
| – | – |
|
|
MOBL
99
DELISTED
MobileIron, Inc.
MOBL
| $70K | 0.06% |
+14,500
| New | +$77.2K |
|
100
Senseonics Holdings Inc
SENS
$263M
| $56K | 0.05% |
3,075
+550
| +22% | +$10.8K |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
FTEA
WT
BAM
Perkins Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Perkins Capital Management held 122 positions worth $112M, down 3.9% from $116M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Perkins Capital Management withdrew a net $14.3M in Q4 2019, closing 9 positions and reducing 73 holdings. Its most notable exit was Cantaloupe, an estimated $1.71M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 62% a quarter earlier, followed by Technology and Industrials.
Against the trend, Perkins Capital Management opened a new position in Qumu Corp. worth $1.11M.
- Perkins Capital Management's largest Q4 2019 buy was Qumu Corp.: 427,000 shares worth $1.11M.
- Perkins Capital Management added most to Akoustis Technologies Inc in Q4 2019, an estimated $759K increase.
- Perkins Capital Management's biggest Q4 2019 reduction was Apyx Medical, cutting an estimated $1.13M.
- Perkins Capital Management fully exited Cantaloupe in Q4 2019, selling an estimated $1.71M.
- Perkins Capital Management's ten largest holdings make up 35% of its $112M portfolio in Q4 2019.
- Perkins Capital Management opened 10 new positions and closed 9 in Q4 2019.
- Perkins Capital Management's portfolio value fell 3.9% quarter-over-quarter to $112M.
Based on Perkins Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.